MX352891B - Purgantes electroliticos. - Google Patents

Purgantes electroliticos.

Info

Publication number
MX352891B
MX352891B MX2014004962A MX2014004962A MX352891B MX 352891 B MX352891 B MX 352891B MX 2014004962 A MX2014004962 A MX 2014004962A MX 2014004962 A MX2014004962 A MX 2014004962A MX 352891 B MX352891 B MX 352891B
Authority
MX
Mexico
Prior art keywords
compositions
water
soluble
purgatives
sulphate
Prior art date
Application number
MX2014004962A
Other languages
English (en)
Other versions
MX2014004962A (es
Inventor
Julius Borody Thomas
Ramrakha Sanjay
Saxon John
Wettstein Antony
Original Assignee
Salix Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Salix Pharmaceuticals Inc filed Critical Salix Pharmaceuticals Inc
Publication of MX2014004962A publication Critical patent/MX2014004962A/es
Publication of MX352891B publication Critical patent/MX352891B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Detergent Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La invención proporciona las composiciones para el uso en purgantes, para el uso como purgantes, y a los métodos para inducir la purga del colon. En modalidades alternativas, la invención proporciona las composiciones, por ejemplo, un purgante, que comprende: una sal de sodio soluble en agua (especialmente sulfato de sodio), una sal de potasio soluble en agua (especialmente sulfato de potasio), y una sal de magnesio soluble en agua (especialmente sulfato de magnesio); y las composiciones que comprenden además: bisoxatina, o un agente detergente ablandador de las heces (tal como picosulfato de sodio) y/o un azúcar soluble en agua (tal como xilosa o equivalente); o las composiciones que tienen estos ingredientes en diferentes cantidades, pero en proporciones equivalentes. En modalidades alternativas, la invención proporciona las composiciones purgantes que comprenden electrolitos, sales, azúcares, bisoxatina, colorantes y rompedores de biopelícula.
MX2014004962A 2011-10-27 2012-10-27 Purgantes electroliticos. MX352891B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161552431P 2011-10-27 2011-10-27
US201261717599P 2012-10-23 2012-10-23
PCT/AU2012/001315 WO2013059881A1 (en) 2011-10-27 2012-10-27 Electrolyte purgatives

Publications (2)

Publication Number Publication Date
MX2014004962A MX2014004962A (es) 2015-01-16
MX352891B true MX352891B (es) 2017-12-13

Family

ID=48166953

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014004962A MX352891B (es) 2011-10-27 2012-10-27 Purgantes electroliticos.

Country Status (13)

Country Link
US (1) US20150056140A1 (es)
EP (1) EP2782581A4 (es)
JP (2) JP6240610B2 (es)
KR (1) KR20140090217A (es)
CN (1) CN104010642B (es)
AU (2) AU2012327212B2 (es)
BR (1) BR112014009946A2 (es)
CA (1) CA2853520C (es)
IL (1) IL232218B (es)
IN (1) IN2014DN03373A (es)
MX (1) MX352891B (es)
RU (1) RU2640920C2 (es)
WO (1) WO2013059881A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2821196C (en) 2010-12-13 2022-11-22 Thomas Julius Borody Gastric and colonic formulations and methods for making and using them
TWI535461B (zh) 2011-03-11 2016-06-01 諾金私人有限公司 結腸清潔溶液、用於製備該溶液之組成物、包含該組成物或溶液之套組、與製備該溶液之方法
TR201904884T4 (tr) 2012-07-27 2019-05-21 Redhill Biopharma Ltd Koloni̇k boşaltmada kullanima yöneli̇k formülasyonlar ve formülasyonlarin üreti̇m yöntemleri̇
ES2909386T3 (es) 2012-09-11 2022-05-06 Norgine Bv Composiciones que comprenden polietilenglicol y sulfatos de metales alcalinos o alcalinotérreos para su uso como composiciones de limpieza de colon
AU2014227598B2 (en) 2013-03-15 2018-12-06 Braintree Laboratories, Inc. Dual use oral pharmaceutical composition tablets of sulfate salts and methods of use thereof
CN103585173B (zh) * 2013-10-28 2016-06-29 王显著 含硫酸钠和匹可硫酸的药物组合物
WO2016040733A1 (en) * 2014-09-12 2016-03-17 Braintree Laboratories, Inc. Sulfate salt solution laxative compositions and methods of use thereof
FR3049464B1 (fr) * 2016-03-29 2021-08-06 Marc Girard Preparations coliques
US10143656B1 (en) 2017-08-04 2018-12-04 Braintree Laboratories, Inc. Solid oral sulfate salt formulations for cleaning a colon and methods of using same
KR102127003B1 (ko) * 2017-10-12 2020-06-25 주식회사 한국팜비오 황산염을 포함하는 대장 하제 조성물
CN108244627A (zh) * 2018-01-16 2018-07-06 广西天昌投资有限公司 一种具有润肠功能的香蕉口服液及其制备方法
KR102111094B1 (ko) * 2018-06-18 2020-05-14 주식회사 한국팜비오 무수황산나트륨, 황산칼륨, 무수황산마그네슘 및 시메티콘을 포함하는 장관하제 경구투여용 고형제제 조성물
RU2699222C1 (ru) * 2019-04-29 2019-09-04 Алексей Владимирович Воронов Солевой электролитный раствор для проведения энтеральных инфузий
RU2709495C1 (ru) * 2019-08-01 2019-12-18 Общество с ограниченной ответственностью "Гелеспон" Способ очищения кишечника и набор для его осуществления
KR20220122613A (ko) * 2019-12-23 2022-09-02 주식회사 비보존 대장 하제 조성물
KR20220033810A (ko) * 2020-09-10 2022-03-17 강윤식 장 정결용 보조 음료

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6162464A (en) * 1997-03-31 2000-12-19 Inkine Pharmaceutical, Inc. Non-aqueous colonic purgative formulations
JP2000060487A (ja) * 1998-08-27 2000-02-29 Kao Corp 便秘改善剤
EE04580B1 (et) * 2001-06-29 2006-02-15 Tartu �likool Mikroorganismi tüvi Lactobacillus fermentum ME-3 kui antimikroobne ja antioksüdantne probiootikum
US7101573B2 (en) * 2001-09-28 2006-09-05 Mcneil-Pcc, Inc. Simethicone solid oral dosage form
AUPS088702A0 (en) * 2002-03-04 2002-03-28 Borody, Thomas Julius Electrolyte purgative
JP4458761B2 (ja) * 2003-03-27 2010-04-28 ロート製薬株式会社 瀉下用製剤
US7687075B2 (en) * 2003-11-19 2010-03-30 Salix Pharmaceuticals, Ltd. Colonic purgative composition with soluble binding agent
GB0409104D0 (en) * 2004-04-23 2004-05-26 Norgine Europe Bv Compressed pharmaceutical compositions
US9125833B2 (en) * 2005-11-02 2015-09-08 Relmada Therapeutics, Inc. Multimodal abuse resistant and extended release opioid formulations
WO2007057924A1 (en) * 2005-11-21 2007-05-24 Panacea Biotec Ltd Laxative composition on the basis of triphala
WO2008021394A2 (en) * 2006-08-15 2008-02-21 Theraquest Biosciences, Llc Pharmaceutical formulations of cannabinoids and method of use
JP2008115085A (ja) * 2006-11-01 2008-05-22 Tendou Seiyaku Kk 緩下剤
US20090155363A1 (en) * 2007-12-14 2009-06-18 Todd Maibach Methods for oral administration of active drugs
US20090258090A1 (en) * 2008-04-11 2009-10-15 Braintree Laboratories, Inc. Colon cleansing solution
JP2011135936A (ja) * 2009-12-25 2011-07-14 Toshiba Corp 画像処理装置、医用画像診断装置および画像処理プログラム
CA2821196C (en) * 2010-12-13 2022-11-22 Thomas Julius Borody Gastric and colonic formulations and methods for making and using them
CA2825808C (en) * 2011-01-28 2020-09-01 William A. Shaver Method, composition and package for bowel cleansing

Also Published As

Publication number Publication date
EP2782581A1 (en) 2014-10-01
AU2016213892B2 (en) 2018-04-05
CN104010642A (zh) 2014-08-27
WO2013059881A1 (en) 2013-05-02
JP2015510491A (ja) 2015-04-09
IN2014DN03373A (es) 2015-06-05
AU2012327212A1 (en) 2013-05-23
RU2640920C2 (ru) 2018-01-12
EP2782581A4 (en) 2015-05-20
IL232218B (en) 2018-10-31
US20150056140A1 (en) 2015-02-26
AU2016213892A1 (en) 2016-09-01
JP2018008997A (ja) 2018-01-18
CA2853520C (en) 2021-11-16
JP6240610B2 (ja) 2017-11-29
NZ624088A (en) 2016-09-30
CN104010642B (zh) 2018-08-17
AU2012327212B2 (en) 2016-05-12
NZ723576A (en) 2018-07-27
KR20140090217A (ko) 2014-07-16
BR112014009946A2 (pt) 2017-04-25
IL232218A0 (en) 2014-06-30
CA2853520A1 (en) 2013-05-02
MX2014004962A (es) 2015-01-16
RU2014121255A (ru) 2015-12-10

Similar Documents

Publication Publication Date Title
MX352891B (es) Purgantes electroliticos.
AR087845A1 (es) Articulos estables solubles en agua de dosis unitaria
NZ743984A (en) Compositions comprising polyethylene glycol, alkali metal or alkaline earth metal sulphates and electrolytes for use as colon cleansing compositions
IN2012DN00306A (es)
WO2011110347A3 (en) Compositions for colon lavage and methods of making and using same
BR112013028907A2 (pt) conjugados de proteína-agente ativo e método para preparar os mesmos
BR112012017062A2 (pt) "composições deterfgentes contendo lipase de geobacillus stearothermophilus e métodos para uso das mesmas"
MX2014003279A (es) Composiciones detergentes que comprenden relaciones de mezclas especificas entre surfactantes basados en isoprenoides.
SG195086A1 (en) Compounds containing hydrido-tricyano-borate anions
MX336810B (es) Benzoxazepinonas fusionadas como moduladoras de canales ionicos.
IN2014DN09938A (es)
BR112014032910A2 (pt) solfactants de éter de glicerina etoxilado
MX2009008279A (es) Detergente solido de disolucion rapida.
AR080992A1 (es) Una composicion de tratamiento que comprende complejos polielectrolitos
NZ595785A (en) Improvements in and relating to colon cleansing compositions
MX2013011487A (es) Preparaciones para composiciones de limpieza multiuso.
MX2010007603A (es) Combinacion biocida para utilizacion en aplicaciones agricolas.
SG144842A1 (en) Method for improving the performance of nickel electrodes
MX339413B (es) Composiciones liquidas de limpieza y desinfeccion.
MX2012015203A (es) Composiciones transparentes de limpieza de baja irritacion con ph relativamente bajo.
MX2012000767A (es) Composicion y metodo.
BR112012026659A2 (pt) composto para desinfecção de superfícies.
ZA201108504B (en) Immunogenic compositions having low sodium chloride concentration
BR112014016115A2 (pt) produto de limpeza neutro para pavimentos
WO2010056527A3 (en) B-biphenyl sulfonamide compounds as ion channel modulators

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: SALIX PHARMACEUTICALS, INC.

FG Grant or registration